QQQS Invesco NASDAQ Future Gen 200 ETF

42

NASDAQ | ETF

Price
$25.26
Increased by +1.41%
Dollar Volume (20D)
61.61 K
ADR%
1.52

Top 20 Holdings

Asset Name Sector Industry Weight
OCUL Ocular Therapeutix Inc Healthcare Biotechnology 1.62%
ALT Altimmune Inc Healthcare Biotechnology 1.54%
MRSN Mersana Therapeutics Inc Healthcare Biotechnology 1.32%
FATE Fate Therapeutics Inc Healthcare Biotechnology 1.14%
IOVA Iovance Biotherapeutics Inc Healthcare Biotechnology 1.05%
KOD Kodiak Sciences Inc Healthcare Biotechnology 1%
LXRX Lexicon Pharmaceuticals Inc Healthcare Biotechnology 0.94%
ESPR Esperion Therapeutics Inc Healthcare Drug Manufacturers - Specialty & Generic 0.94%
ALPN Alpine Immune Sciences Inc Healthcare Biotechnology 0.91%
SIGA SIGA Technologies Inc Healthcare Drug Manufacturers - Specialty & Generic 0.89%
MGNX MacroGenics Inc Healthcare Biotechnology 0.88%
KURA Kura Oncology Inc Healthcare Biotechnology 0.88%
HRTX Heron Therapeuti Healthcare Biotechnology 0.85%
ARDX Ardelyx Inc Healthcare Biotechnology 0.84%
GERN Geron Corporation Healthcare Biotechnology 0.83%
ARVN Arvinas Inc Healthcare Biotechnology 0.82%
KALV Kalvista Pharmaceuticals Inc Healthcare Biotechnology 0.82%
HEAR Turtle Beach Corp Technology Consumer Electronics 0.81%
GRTS Gritstone Oncology Inc Healthcare Biotechnology 0.8%
INO Inovio Pharmaceuticals Inc Healthcare Biotechnology 0.79%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY

The fund generally will invest at least 90% of its total assets in the securities that comprise the index. The index excludes securities of issuers included in the Nasdaq-100 Index® (an index that measures the performance of 100 of the largest Nasdaq-listed non-financial companies by market capitalization) and the Nasdaq Next Generation 100 Index® (an index that measures the performance of the 100 largest Nasdaq-listed companies outside of the NASDAQ-100 Index® based on market capitalization). The fund is non-diversified.